✦ LIBER ✦

PMH62 ECONOMIC OUTCOMES OF CO-TREATMENT OF INSOMNIA AND MAJOR DEPRESSIVE DISORDER (MDD) WITH ESZOPICLONE AND FLUOXETINE VERSUS FLUOXETINE TREATMENT ALONE

✍ Scribed by SS Snedecor; MM Botteman; K Schaefer; P Sarocco; N Barry; AA Pickard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Placebo-controlled study of ABT-200 vers

✍ John J. Sramek; Kenneth Kashkin; Olga Jasinsky; David Kardatzke; Sara Kennedy; N 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

Venlafaxine XR versus fluoxetine in the

✍ D. Vasile; O. Vasiliu; P. Ivanov; D. Ojog; M. Sarmache; M. Vasile 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 43 KB

P02-74 - Medical and economic benefit of

✍ E. Ostad Haji; A. Tadic; A. Dragicevic; M. Müller; K. Boland; M.L. Rao; M. Fric; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 French ⚖ 25 KB

Comparable efficacy and safety of 8 week

✍ Shu, L.; Sulaiman, A.H.; Huang, Y.S.; Fones Soon Leng, C.; Crutel, V. Strijckman 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 378 KB

Type of residual symptom and risk of rel

✍ Huaiyu Yang; Sarah Chuzi; Lara Sinicropi-Yao; Dan Johnson; Ying Chen; Alisabet C 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 155 KB

PMH19 ECONOMIC ASSESSMENT OF SECOND-LINE

✍ M Marynchenko; AP Yu; V Lauzon; K Ramakrishnan; EQ Wu; R Ben-Hamadi; MH Erder; A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB